Literature DB >> 16630585

Antibody-mediated Hsp70 protein therapy.

James E Hansen1, William Sohn, Charles Kim, Sophia S Chang, Natalie C Huang, Donaldson G Santos, Grace Chan, Richard H Weisbart, Robert N Nishimura.   

Abstract

Intracellular Hsp70 provides cytoprotection against a variety of stressful stimuli, and an effective means of increasing intracellular Hsp70 levels could prove beneficial in the prevention and treatment of a variety of human diseases. A novel protein transduction domain consisting of the single chain Fv fragment of an anti-DNA antibody known to penetrate into living cells and tissues, mAb 3E10, has recently been used to deliver functional proteins to cells. The ability of the single chain Fv fragment to deliver Hsp70 into living cells was tested by generating an Fv-Hsp70 fusion protein. Fv-Hsp70 was produced as a secreted protein in both COS-7 cells and the methylotropic yeast strain Pichia pastoris and was shown capable of penetrating into COS-7 cells and primary rat cortical neurons. Pre-treatment with Fv-Hsp70 protected both COS-7 cells and primary rat cortical neurons against subsequent exposure to hydrogen peroxide. These results provide the first evidence that the Fv fragment of mAb 3E10 is capable of delivering proteins to neurons and indicate its potential in the development of Hsp70 protein therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630585     DOI: 10.1016/j.brainres.2006.03.025

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.

Authors:  Haiqing Yi; Tao Sun; Dustin Armstrong; Scott Borneman; Chunyu Yang; Stephanie Austin; Priya S Kishnani; Baodong Sun
Journal:  J Mol Med (Berl)       Date:  2017-02-02       Impact factor: 4.599

2.  Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

Authors:  M Kathryn Brewer; Annette Uittenbogaard; Grant L Austin; Dyann M Segvich; Anna DePaoli-Roach; Peter J Roach; John J McCarthy; Zoe R Simmons; Jason A Brandon; Zhengqiu Zhou; Jill Zeller; Lyndsay E A Young; Ramon C Sun; James R Pauly; Nadine M Aziz; Bradley L Hodges; Tracy R McKnight; Dustin D Armstrong; Matthew S Gentry
Journal:  Cell Metab       Date:  2019-07-25       Impact factor: 27.287

Review 3.  Targeted heat shock protein 72 for pulmonary cytoprotection.

Authors:  Missag H Parseghian; Stephen T Hobson; Richard A Richieri
Journal:  Ann N Y Acad Sci       Date:  2016-05-06       Impact factor: 5.691

4.  Cardioprotective Effects of HSP72 Administration on Ischemia-Reperfusion Injury.

Authors:  Takashi Tanimoto; Missag H Parseghian; Takehiro Nakahara; Hideki Kawai; Navneet Narula; Dongbin Kim; Robert Nishimura; Richard H Weisbart; Grace Chan; Richard A Richieri; Nezam Haider; Farhan Chaudhry; Glenn T Reynolds; John Billimek; Francis G Blankenberg; Partho P Sengupta; Artiom D Petrov; Takashi Akasaka; H William Strauss; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2017-09-19       Impact factor: 24.094

5.  Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats.

Authors:  Xinhua Zhan; Bradley P Ander; Isaac H Liao; James E Hansen; Chester Kim; Douglas Clements; Richard H Weisbart; Robert N Nishimura; Frank R Sharp
Journal:  Stroke       Date:  2010-01-14       Impact factor: 7.914

6.  Targeting cancer with a lupus autoantibody.

Authors:  James E Hansen; Grace Chan; Yanfeng Liu; Denise C Hegan; Shibani Dalal; Eloise Dray; Youngho Kwon; Yuanyuan Xu; Xiaohua Xu; Elizabeth Peterson-Roth; Erik Geiger; Yilun Liu; Joseph Gera; Joann B Sweasy; Patrick Sung; Sara Rockwell; Robert N Nishimura; Richard H Weisbart; Peter M Glazer
Journal:  Sci Transl Med       Date:  2012-10-24       Impact factor: 17.956

Review 7.  DNA-damaging autoantibodies and cancer: the lupus butterfly theory.

Authors:  Philip W Noble; Sasha Bernatsky; Ann E Clarke; David A Isenberg; Rosalind Ramsey-Goldman; James E Hansen
Journal:  Nat Rev Rheumatol       Date:  2016-03-24       Impact factor: 20.543

8.  The development of modified human Hsp70 (HSPA1A) and its production in the milk of transgenic mice.

Authors:  Yaroslav G Gurskiy; David G Garbuz; Nataliya V Soshnikova; Aleksey N Krasnov; Alexei Deikin; Vladimir F Lazarev; Dmitry Sverchinskyi; Boris A Margulis; Olga G Zatsepina; Vadim L Karpov; Svetlana N Belzhelarskaya; Evgenia Feoktistova; Sofia G Georgieva; Michael B Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2016-08-10       Impact factor: 3.667

Review 9.  Antibody-Mediated Enzyme Therapeutics and Applications in Glycogen Storage Diseases.

Authors:  Zhengqiu Zhou; Grant L Austin; Robert Shaffer; Dustin D Armstrong; Matthew S Gentry
Journal:  Trends Mol Med       Date:  2019-09-12       Impact factor: 11.951

10.  Altered expression of HSP70 in oral lichen planus.

Authors:  Nutan Tyagi; Devi Charan Shetty; Aadithya B Urs
Journal:  J Oral Maxillofac Pathol       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.